Molecular mechanism by which miR-26b regulates fatty acid-binding protein 4-mediated adipocyte differentiation

doi:10.12307/2022.042

Abstract

Abstract: BACKGROUND: The roles of miR-26b, PTEN-PI3K-AKT pathway and fatty acid-binding protein 4 (FABP4) in the process of adipocyte differentiation have been confirmed, but whether there is an interaction and their molecular mechanisms have not been reported yet.
OBJECTIVE: To investigate the molecular mechanism by which miR-26b regulates FABP4-mediated adipocyte differentiation through the PTEN-PI3K-AKT pathway.
METHODS: 3T3-L1 preadipocytes were set as control group, 3T3-L1 cells maturely differentiated as differentiation group, 3T3-L1 cells transfected with miR-26b inhibitor as transfection group, and 3T3-L1 cells that were transfected with miR-26b inhibitor and then induced to differentiate were used as transfected differentiation group. Oil red O staining observed lipid droplets in mature adipocytes in the differentiation group and transfected differentiation group. Fluorescence quantitative PCR was used to detect the mRNA expression of miR-26b and FABP4, PTEN, PI3K and AKT in the cells. Western blot assay was used to identify the protein expression of FABP4, PTEN, PI3K and AKT in the cells.
RESULTS AND CONCLUSION: (1) The expression of miR-26b was significantly increased after 3T3-L1 cell differentiation (P < 0.05), suggesting that it may be involved in the regulation of cell differentiation. Inhibiting the level of miR-26b in the cells could inhibit the differentiation of 3T3-L1 cells into adipocytes and reduce the accumulation of intracellular lipid droplets. (2) The mRNA and protein expression of PI3K, AKT, and FABP4 in the 3T3-L1 cells increased significantly after differentiation (P < 0.01). Although PTEN mRNA expression increased (P < 0.05), the protein level did not change obviously (P > 0.05), suggesting that during the differentiation of 3T3-L1 cells, the PI3K-AKT pathway in the cells is activated and the level of FABP4 is increased. (3) Compared with normal differentiated cells, the mRNA and protein expressions of FABP4, PI3K, and AKT in differentiated cells in which the level of intracellular miR-26b was downregulated were significantly decreased (P < 0.01), while the mRNA and protein expressions of PTEN increased (P < 0.05), suggesting that inhibition of miR-26b significantly promoted mRNA and protein expression of PTEN, thereby inhibited PI3K-AKT pathway, reduced mRNA and protein expression of FABP4, and then inhibited 3T3-L1 cell differentiation.

Key words: fatty acid-binding protein 4, miR-26b, adipocyte, differentiation, PTEN, PI3K, AKT, signaling pathway

CLC Number:

Na Risong, Sun Liang, Zhao Zhenqun, Liang Rong, Wang Xin. Molecular mechanism by which miR-26b regulates fatty acid-binding protein 4-mediated adipocyte differentiation[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(2): 260-265.

Figures/Tables 4

References

[1] Palmer AK, Kirkland JL. Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. Exp Gerontol. 2016;86:97-105.
[2] Ahima RS. Connecting obesity, aging and diabetes. Nat Med. 2009; 15(9):996-997.
[3] Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(3):235-241.
[4] Maurizi G, Della Guardia L, Maurizi A, et al. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. J Cell Physiol. 2018;233(1):88-97.
[5] Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177-185.
[6] Prentice KJ, Saksi J, Hotamisligil GS. Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses. J Lipid Res. 2019;60(4):734-740.
[7] Shi C, Huang F, Gu X, et al. Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity. Oncotarget. 2016;7(26):40830-40845.
[8] Li G, Ning C, Ma Y, et al. miR-26b Promotes 3T3-L1 Adipocyte Differentiation Through Targeting PTEN. DNA Cell Biol. 2017;36(8): 672-681.
[9] Friedman JM. Obesity in the new millennium. Nature. 2000;404 (6778):632-634.
[10] Lutz A. Internalising dietary norms and transforming food practices: social inequalities in the management of childhood obesity. Health Sociol Rev. 2020;29(1):16-30.
[11] Skelton JA, Palakshappa D, Moore JB, et al. Community engagement and pediatric obesity: Incorporating social determinants of health into treatment. J Clin Transl Sci. 2019;4(4):279-285.
[12] Zhong H, Ma M, Liang T, et al. Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response. J Immunol Res. 2018;2018:2835761.
[13] Goody D, Pfeifer A. MicroRNAs in brown and beige fat. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(1):29-36.
[14] Furuhashi M, Saitoh S, Shimamoto K, et al. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin Med Insights Cardiol. 2015;8(Suppl 3):23-33.
[15] Sun J, Zhang D, Xu J, et al. Circulating FABP4, nesfatin-1, and osteocalcin concentrations in women with gestational diabetes mellitus: a meta-analysis. Lipids Health Dis. 2020;19(1):199.
[16] Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs--mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015; 11(10):592-605.
[17] Yang VW, Christy RJ, Cook JS, et al. Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation. Proc Natl Acad Sci U S A. 1989;86(10):3629-3633.
[18] Rodríguez-Calvo R, Girona J, Alegret JM, et al. Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease. J Endocrinol. 2017;233(3):R173-R184.
[19] Trojnar M, Patro-Małysza J, Kimber-Trojnar Ż, et al. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus. Cells. 2019;8(3):227.
[20] Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia. 2013;56(1):10-21.
[21] Elie AGIM, Bloksgaard M, Sun WY, et al. Local enrichment of fatty acid-binding protein 4 in the pericardial cavity of cardiovascular disease patients. PLoS One. 2018;13(11):e0206802.
[22] Demirsoy İH, Ertural DY, Balci Ş, et al. Profiles of Circulating MiRNAs Following Metformin Treatment in Patients with Type 2 Diabetes. J Med Biochem. 2018;37(4):499-506.
[23] Stępień EŁ, Durak-Kozica M, Kamińska A, et al. Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes. Theranostics. 2018;8(14):3874-3890.
[24] Xu G, Ji C, Song G, et al. Obesity-associated microRNA-26b regulates the proliferation of human preadipocytes via arrest of the G1/S transition. Mol Med Rep. 2015;12(3):3648-3654.
[25] Yu ZW, Eriksson JW. The upregulating effect of insulin and vanadate on cell surface insulin receptors in rat adipocytes is modulated by glucose and energy availability. Horm Metab Res. 2000;32(8):310-315.
[26] 迟毓婧,李晶,管又飞,等.PI3K-Akt信号传导通路对糖代谢的调控作用[J].中国生物化学与分子生物学报,2010,26(10):879-885.
[27] Zhang L, Huang C, Guo Y, et al. MicroRNA-26b Modulates the NF-κB Pathway in Alveolar Macrophages by Regulating PTEN. J Immunol. 2015;195(11):5404-5414.
[28] Xu G, Ji C, Song G, et al. MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway. Int J Obes (Lond). 2015;39(10):1523-1530.
[29] Makowski L, Brittingham KC, Reynolds JM, et al. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem. 2005;280(13):12888-12895.
[30] Dong X, Yang L. Inhibition of fatty acid binding protein 4 attenuates gestational diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2020;161:102179.